FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma.

Justin Ferdinandus,Ines Maric,Christopher Darr,Claudia Kesch,Thomas Hilser,Wolfgang P. Fendler,Ken Herrmann,Boris Hadaschik,Viktor Grünwald

FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinoma.

2021

Justin Ferdinandus
Ines Maric
Christopher Darr
Claudia Kesch
Thomas Hilser
Wolfgang P. Fendler
Ken Herrmann
Boris Hadaschik
Viktor Grünwald

e16564Background: Positron emission tomography with (18F)-fluorodeoxyglucose (FDG-PET) is not considered a standard of care (SOC) in renal cell carcinoma (RCC) because of its variability in metabol...

Keywords:

Internal medicine
Medicine
prognostic biomarker
Positron emission tomography
Oncology
Renal cell carcinoma
Avidity
overall survival
standard of care

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations